人類乳突病毒感染之非小細胞肺癌患者臨床預後及抗藥性生物指標之建立

Medicine & Life Sciences

1. Lung Neoplasms 100%
2. MicroRNAs 63%
3. TL 1 33%
4. Biomarkers 21%
5. Neoplasms 19%
6. Papillomavirus Infections 18%
7. Taiwan 16%
8. Drug Resistance 15%
9. Cisplatin 15%
10. Recurrence 14%
11. Pharmaceutical Preparations 13%
12. Animal Models 12%
13. Primary Cell Culture 10%
14. Drug Therapy 9%
15. Therapeutics 9%
16. Survival 9%
17. Preliminary Data 9%
18. Precision Medicine 9%
19. Non-Smokers 8%
20. Drug Delivery Systems 8%
21. RNA Interference 8%
22. Heterografts 7%
23. Non-Small Cell Lung Carcinoma 7%
24. Transfection 7%
25. Early Diagnosis 6%
26. Cause of Death 6%
27. Interleukin-6 6%
28. Survival Rate 6%